Stay updated with breaking news from Controlled Substances. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Brooke Worster, MD, MS, FACP, and chief medical officer at EO Care, details what oncologists should know about medical cannabis pending the expectant marijuana reclassification from a Schedule I to a Schedule III drug.
What does Cybin’s regulatory momentum and significant financial backing mean for the broader psychedelics space?
People have been buying drugs — illegal and otherwise — online for around as long as the internet itself. As restrictions loosen in some states, providers have begun popping up
The chemical company violated certain regulatory recordkeeping requirements, the DEA alleges.
In an address before the Truckload Carriers Association, the FMCSA’s leader commends trucking leaders for their commitment to safety and lays out the agency’s focus on reducing...